Log in or Sign up for Free to view tailored content for your specialty!
ADD/ADHD News
Methylphenidate improved outcomes of group psychotherapy, individual counseling for adult ADHD
Among adults with attention-deficit/hyperactivity disorder, cognitive behavioral group psychotherapy did not outperform individual clinical management, however, the addition of methylphenidate improved outcomes of psychological interventions.
ADHD affects white matter differently in boys, girls
Attention-deficit/hyperactivity disorder affects white matter differently in boys and girls, according to study findings in the Journal of the American Academy of Child and Adolescent Psychiatry.
Log in or Sign up for Free to view tailored content for your specialty!
Electronic decision support improves ADHD treatment guideline adherence
WASHINGTON — The use of an electronic template and a uniform workflow improved adherence to AAP evidence-based guidelines for the treatment of attention-deficit hyperactivity disorder with stimulant medication, according to data presented at the 2015 AAP National Conference and Exhibition.
Medicaid-covered children in foster care at increased risk for ADHD
WASHINGTON — Children in foster care and enrolled in Medicaid were at more than three times greater risk for attention-deficit/hyperactivity disorder compared with other pediatric Medicaid recipients, according to data presented at the 2015 AAP National Conference and Exhibition.
Autism diagnosis should be considered in children with ADHD
Diagnostic consideration for autism spectrum disorder is required when making a diagnosis of attention-deficit/hyperactivity disorder, due to the prevalence of detrimentally late diagnosis of ASD in children with concurrent disorders, according to recent data in Pediatrics.
Guanfacine extended-release efficacious, well-tolerated for adolescent ADHD
Results from a 13-week, multicenter, randomized, double blind, placebo-controlled trial indicate guanfacine extended-release was associated with significant improvement in attention deficit/hyperactivity disorder symptoms in adolescents.
Psychostimulants may reduce risk for anxiety in children with ADHD
Results from a meta-analysis show a reduced risk for anxiety among children with attention-deficit/hyperactivity disorder receiving psychostimulant treatment compared with those receiving placebo.
Psychostimulants may reduce risk for anxiety in children with ADHD
Results from a meta-analysis show a reduced risk for anxiety among children with attention-deficit/hyperactivity disorder receiving psychostimulant treatment compared with those receiving placebo.
Stimulant medications determined safe for children with ADHD, heart disease
Children with attention-deficit/hyperactivity disorder and congenital heart disease can use stimulant medications without facing potential cardiovascular side effects, according to study results presented at the annual meeting of the Society for Developmental and Behavioral Pediatrics in Las Vegas.
Meta-analysis shows significant association between ADHD, obesity in children, adults
Results from a meta-analysis published in the American Journal of Psychiatry indicated a significant association between obesity and attention-deficit/hyperactivity disorder among children and adults.
-
Headline News
CDC: 1 dead in multistate outbreak of E. coli linked to organic carrots
November 18, 20241 min read -
Headline News
Obesity drugs could help lower alcohol intake
November 18, 20243 min read -
Headline News
Pediatric asthma ‘potential source of cognitive difficulty’
November 18, 20242 min read
-
Headline News
CDC: 1 dead in multistate outbreak of E. coli linked to organic carrots
November 18, 20241 min read -
Headline News
Obesity drugs could help lower alcohol intake
November 18, 20243 min read -
Headline News
Pediatric asthma ‘potential source of cognitive difficulty’
November 18, 20242 min read